Pacific Biosciences of California is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Christian O. Henry, with a market cap of $522.5M.
Common questions about Pacific Biosciences of California
Pacific Biosciences of California is scheduled to report earnings for Q1 2026 on May 7, 2026 after market close. Analysts estimate revenue of $40.0M.
Pacific Biosciences of California has approximately 796 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.